Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Allogene Therapeutics
Massachusetts General Hospital
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
AvenCell Therapeutics, Inc.
University of Chicago
Dana-Farber Cancer Institute
University of Washington
Genmab
Genmab
Genmab
Malaghan Institute of Medical Research
Fred Hutchinson Cancer Center
Lyell Immunopharma, Inc.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
AIDS Malignancy Consortium
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Regeneron Pharmaceuticals
Medical College of Wisconsin
Mayo Clinic
SWOG Cancer Research Network
University of Wisconsin, Madison
Massachusetts General Hospital
University of Michigan Rogel Cancer Center
Masonic Cancer Center, University of Minnesota
University of Washington
University of California, San Francisco
Fred Hutchinson Cancer Center
Stichting Hemato-Oncologie voor Volwassenen Nederland
National Institutes of Health Clinical Center (CC)
University of Washington
Ruijin Hospital
Gilead Sciences
Sana Biotechnology
Memorial Sloan Kettering Cancer Center
Henan Cancer Hospital
Massachusetts General Hospital
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
City of Hope Medical Center
Sana Biotechnology
Centre Antoine Lacassagne
Fred Hutchinson Cancer Center